Wednesday, February 20, 2013

Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 93 Issue 3


Advertisement

Click Here to download the OncologyMAP Application Notes and learn about how OncologyMAP v2.0 can help you accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring.


TABLE OF CONTENTS

Volume 93, Issue 3 (March 2013)

In this issue
In This Issue
Editorial
News & Views
Perspectives
Development
Discovery
Regulation & Use
State of the Art
Reviews
Research

Also new
AOP
Sign up for e-alerts Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Meet the Editors of Clinical Pharmacology & Therapeutics and CPT: Pharmacometrics & Systems Pharmacology

Join us at the ASCPT Annual Meeting March 8, 2013. View complete details here.
 

In This Issue

Top

In This Issue

Clin Pharmacol Ther 2013 93: 213; 10.1038/clpt.2012.267

Full Text

Editorial

Top

Integrating Clinical Pharmacology Concepts in Individualized Therapy With Tyrosine Kinase Inhibitors

C D Drenberg, S D Baker and A Sparreboom

Clin Pharmacol Ther 2013 93: 215-219; 10.1038/clpt.2012.247

Abstract | Full Text

News & Views

Top

HIGHLIGHTS

Clin Pharmacol Ther 2013 93: 220-221; 10.1038/clpt.2012.266

Full Text

ASCPT NEWS

Clin Pharmacol Ther 2013 93: 222-227; 10.1038/clpt.2012.248

Full Text

MACROSCOPY

Without Therapeutic Drug Monitoring, There Is No Personalized Cancer Care

J H Beumer

Clin Pharmacol Ther 2013 93: 228-230; 10.1038/clpt.2012.243

Full Text

Perspectives

Top

COMMENTARY

The State of Clinical Pharmacology Today

J Gray

Clin Pharmacol Ther 2013 93: 231-232; 10.1038/clpt.2012.231

Abstract | Full Text

LETTERS TO THE EDITOR

Doubt About the Feasibility of Preemptive Genotyping

B C P Koch, R H N van Schaik, T van Gelder and R H J Mathijssen on behalf of the Rotterdam Clinical Pharmacology-Pharmacogenetics Group (RCPPG)

Clin Pharmacol Ther 2013 93: 233; advance online publication, December 12, 2012; 10.1038/clpt.2012.191

Full Text

Response to “Doubt About the Feasibility of Preemptive Genotyping”

J C Denny, J S Schildcrout, J M Pulley and D M Roden

Clin Pharmacol Ther 2013 93: 234; advance online publication, November 7, 2012; 10.1038/clpt.2012.223

Full Text

SSRIs: A Premature Burial

K Jensen

Clin Pharmacol Ther 2013 93: 234-235; advance online publication, December 19, 2012; 10.1038/clpt.2012.190

Full Text

Response to “SSRIs: A Premature Burial”

P Weeke and C Torp-Pedersen

Clin Pharmacol Ther 2013 93: 235; advance online publication, December 3, 2012; 10.1038/clpt.2012.232

Full Text

Development

Top

Physiologically Based Pharmacokinetic Models of Tyrosine Kinase Inhibitors: A Systems Pharmacological Approach to Drug Disposition

J M Gallo

Clin Pharmacol Ther 2013 93: 236-238; advance online publication, December 18, 2012; 10.1038/clpt.2012.244

Full Text

Discovery

Top

Imaging of TKI–Target Interactions for Personalized Cancer Therapy

A J Poot, P Slobbe, N H Hendrikse, A D Windhorst and GAMS van Dongen

Clin Pharmacol Ther 2013 93: 239-241; advance online publication, December 12, 2012; 10.1038/clpt.2012.242

Full Text

Regulation & Use

Top

PRACTICE

Playing Russian Roulette With Tyrosine Kinase Inhibitors

R Z Szmulewitz and M J Ratain

Clin Pharmacol Ther 2013 93: 242-244; advance online publication, December 18, 2012; 10.1038/clpt.2012.245

Full Text

State of the Art

Top

Drug Shortages: The Cycle of Quantity and Quality

S L Kweder and S Dill

Clin Pharmacol Ther 2013 93: 245-251; advance online publication, December 6, 2012; 10.1038/clpt.2012.235

Abstract | Full Text

Reviews

Top

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance Open

D Gonzalez de Castro, P A Clarke, B Al-Lazikani and P Workman

Clin Pharmacol Ther 2013 93: 252-259; advance online publication, December 7, 2012; 10.1038/clpt.2012.237

Abstract | Full Text

Gender Differences in Drug Bioequivalence: Time to Rethink Practices

G Koren, H Nordeng and S MacLeod

Clin Pharmacol Ther 2013 93: 260-262; advance online publication, December 3, 2012; 10.1038/clpt.2012.233

Abstract | Full Text

Intracellular Drug Concentrations

C T Dollery

Clin Pharmacol Ther 2013 93: 263-266; advance online publication, December 11, 2012; 10.1038/clpt.2012.240

Abstract | Full Text

Research

Top

ARTICLES

Multiple Dosing of Ephedra-Free Dietary Supplements: Hemodynamic, Electrocardiographic, and Bacterial Contamination Effects

L Foster, M C Allan, A Khan, P Moore, D K Williams, M Hubbard, L Dixon and B J Gurley

Clin Pharmacol Ther 2013 93: 267-274; advance online publication, December 11, 2012; 10.1038/clpt.2012.241

Abstract | Full Text

Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects

M Ulvestad, I B Skottheim, G S Jakobsen, S Bremer, E Molden, A Åsberg, J Hjelmesæth, T B Andersson, R Sandbu and H Christensen

Clin Pharmacol Ther 2013 93: 275-282; advance online publication, December 27, 2012; 10.1038/clpt.2012.261

Abstract | Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: